Qube Research & Technologies (QRT)
AVNS icon

Qube Research & Technologies (QRT)’s Avanos Medical AVNS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
129,593
-573,322
-82% -$7.72M ﹤0.01% 2232
2025
Q4 		$7.89M Sell
702,915
-24,923
-3% -$285K 0.01% 1496
2025
Q3 		$8.41M Buy
727,838
+102,429
+16% +$1.2M 0.01% 1431
2025
Q2 		$7.66M Buy
625,409
+153,547
+33% +$1.93M 0.01% 1461
2025
Q1 		$6.76M Buy
471,862
+360,071
+322% +$5.62M 0.01% 1375
2024
Q4 		$1.78M Buy
+111,791
New +$2.21M ﹤0.01% 1928
2024
Q3 		– Sell
-38,002
Closed -$757K – 3306
2024
Q2 		$757K Sell
38,002
-65,418
-63% -$1.27M ﹤0.01% 2000
2024
Q1 		$2.06M Sell
103,420
-16
-0% -$309 ﹤0.01% 1736
2023
Q4 		$2.32M Buy
103,436
+30,203
+41% +$623K ﹤0.01% 1452
2023
Q3 		$1.48M Buy
73,233
+57,040
+352% +$1.29M ﹤0.01% 1543
2023
Q2 		$414K Buy
+16,193
New +$426K ﹤0.01% 1566
2022
Q4 		– Sell
-18,032
Closed -$393K – 2459
2022
Q3 		$393K Sell
18,032
-1,168
-6% -$30.5K ﹤0.01% 1548
2022
Q2 		$525K Sell
19,200
-9,408
-33% -$270K ﹤0.01% 1388
2022
Q1 		$958K Buy
+28,608
New +$921K 0.01% 1196
2021
Q4 		– Sell
-8,899
Closed -$278K – 2519
2021
Q3 		$278K Sell
8,899
-7,126
-44% -$242K ﹤0.01% 1517
2021
Q2 		$583K Buy
16,025
+6,898
+76% +$285K 0.01% 1203
2021
Q1 		$399K Buy
9,127
+4,586
+101% +$215K 0.01% 1309
2020
Q4 		$208K Buy
+4,541
New +$189K ﹤0.01% 1518
2018
Q4 		– Sell
-1,749
Closed -$120K – 336
2018
Q3 		$120K Buy
1,749
+1,575
+905% +$101K 0.02% 697
2018
Q2 		$10K Buy
+174
New +$9.19K 0.01% 758

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AVNS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Avanos Medical (AVNS) stake by 82% in Q1 2026, selling an estimated $7.72M and leaving 129,593 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Qube Research & Technologies (QRT) first reported a position in AVNS in Q2 2018 and has held it in 20 quarters since. The position peaked at $8.41M in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 129,593 shares of Avanos Medical worth $1.82M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 573,322 Avanos Medical shares in Q1 2026, an estimated $7.72M.
  • Avanos Medical made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2232 holding.
  • Qube Research & Technologies (QRT) first reported a position in Avanos Medical in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Avanos Medical position peaked at $8.41M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.